Filing Details

Accession Number:
0001140361-17-036061
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-20 17:07:08
Reporting Period:
2017-09-18
Accepted Time:
2017-09-20 17:07:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1581720 Loxo Oncology Inc. LOXO Pharmaceutical Preparations (2834) 462996673
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612217 Z. Avi Naider C/O Loxo Oncology, Inc.
281 Tresser Blvd, 9Th Floor
Stamford CT 06901
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-09-18 5,000 $90.00 149,118 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.